Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OKYO PharmaOKYO +2.67%24 Market Cap is $81.34 Mil as of Aug. 22, 2026. GuruFocus rates OKYO with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 1,422 Biotechnology companies, OKYO Pharma ranks worse than 56.75% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). OKYO Pharma's share price for the quarter that ended in Mar. 2026 was $1.61. OKYO Pharma's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 52.48 Mil. Therefore, OKYO Pharma's market cap for the quarter that ended in Mar. 2026 was $84.49 Mil.
OKYO Pharma's quarterly market cap
increased
from Mar. 2025 ($45.75 Mil) to Sep. 2025 ($76.91 Mil) and
increased
from Sep. 2025 ($76.91 Mil) to Mar. 2026 ($84.49 Mil).
OKYO Pharma's annual market cap
declined
from Mar. 2024 ($49.67 Mil) to Mar. 2025 ($45.75 Mil) but then
increased
from Mar. 2025 ($45.75 Mil) to Mar. 2026 ($84.49 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. OKYO Pharma's Enterprise Value for Today is $77.31 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
OKYO Pharma Market Cap Related Terms
OKYO Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for OKYO Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, OKYO Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OKYO Pharma Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OKYO Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where OKYO Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
OKYO Pharma's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OKYO Pharma (OKYO) has a Market Cap of $81.34 Mil as of Aug. 22, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OKYO Pharma and its competitors. According to the industry distribution chart, OKYO Pharma ranks #807 out of 1422 companies in the Biotechnology industry, placing it in the top 56.8%.
Is OKYO Pharma's Market Cap too high?
OKYO Pharma's current Market Cap is $81.34 Mil. The Biotechnology industry median Market Cap is 122.48. OKYO Pharma's value of $81.34 Mil is 33.6% below this industry median. Based on the distribution chart, OKYO Pharma ranks #807 out of 1422 companies in the Biotechnology industry, which is below the industry midpoint. Overall, OKYO Pharma has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does OKYO Pharma's Market Cap compare to ALPS and CGTX?
According to the Biotechnology industry distribution chart, OKYO Pharma ranks #807 out of 1422 companies for Market Cap. This places OKYO Pharma in the lower half of its industry. The industry median Market Cap is 122.48. OKYO Pharma's value of $81.34 Mil is 33.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 122.48, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OKYO Pharma's current Market Cap of $81.34 Mil is 33.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OKYO Pharma and its competitors. For the Biotechnology industry, the median Market Cap is 122.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OKYO Pharma's current Market Cap is $81.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OKYO Pharma stock overvalued right now?
OKYO Pharma (OKYO) has a current Market Cap of $81.34 Mil. The current Market Cap is $81.34 Mil and 33.6% below the Biotechnology industry median of 122.48. OKYO Pharma's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For OKYO Pharma (OKYO), the current Market Cap is $81.34 Mil as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
24GF Score
Get the complete analysis for OKYO
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OKYO has been successfully added to your 
